We observed that patient-derived cSCC tissues exhibited significantly higher levels of 13 different oncogenic proteins (Supplemental Figure S2); 12 of these 13 proteins, including matrix metalloproteinase 2 (MMP2), are known to promote EMT in various cancers. This evidence concerns the gene MMP2 and cancer.